Skip to main content

Table 1 Patient rheumatologic and serum data at baseline and reassessment

From: Effects of tofacitinib on the clinical features of periodontitis in patients with rheumatoid arthritis: two case reports

Parameter Case 1 Case 2
Baseline Reassessment Baseline Reassessment
Rheumatologic
 SDAI 12.3 4.5 16.0 4.0
 DAS28-CRP 2.3 2.9 2.9 2.1
 TJC 2 3 3 1
 SJC 0 0 4 1
 gVAS (mm) 51 7 45 10
Serum
 RF (IU/mL) 5.0 7.0 237.0 174.0
 anti-CCP IgG (U/mL) 37.8 25.7 247.0 301.0
 CRP (mg/dL) 0.1 0.1 0.01 0.01
 MMP-3 (ng/mL) 67.7 70.0 49.9 44.3
 IL-6 (pg/mL) 2.2 1.5 1.9 0.9
 TNF-α (pg/mL) 1.2 0.0 1.0 0.9